Search

everythinglearnresearchcommunity

for

Search:↓

Special cells can help regrow hair in alopecia areata.

Topical immunotherapy with DPCP led to some hair regrowth in most pediatric alopecia areata patients, especially those with milder cases and longer treatment.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Higher levels of IL-1a and IL-1RA were found in severe alopecia areata cases.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Aggressive treatment in young patients with certain drug reactions may lead to multiple autoimmune diseases later.

Mutations in the DSG4 gene cause fragile, sparse hair in humans, mice, and rats.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

Suplatast tosilate successfully treated a woman's systemic sclerosis symptoms.

Hair follicle dermal stem cells help control hair growth timing by regulating signals at the hair germ–dermal papilla interface.

Recognizing unusual symptoms in Crohn's disease is crucial for proper treatment.

Removing MCPIP1 from myeloid cells in mice leads to hair loss and prevents skin tumors but causes pigmented spots.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

New treatments for Dissecting cellulitis show promise, but more research is needed to understand the disease and establish a standard treatment plan.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

Injecting certain cells into mice caused hair loss, which was preventable with a specific inhibitor.

Human mesenchymal stem cells can become dermal papilla cells, aiding hair growth.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Higher levels of PD-L1 are linked to more severe hair loss in people with Alopecia Areata.

Dermal adipose tissue in mice can change and revert to help with skin health.

GLPLS and LPP are variants of lichen planus.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Mesenchymal stem cells in people with Hidradenitis Suppurativa are more inflammatory, possibly contributing to the disease.

The patient likely has Chrousos syndrome, a rare condition causing insensitivity to glucocorticoids, requiring high-dose dexamethasone treatment.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

High-potency steroids or tacrolimus are effective treatments for Erosive Pustular Dermatosis of the Scalp.